Vasoactive Drugs in Intensive Care Unit

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 836 participants.

Also called NCT02118467

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 836 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02118467
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT02118467. Randomized; triple masking; primary purpose treatment. Start 2014-05-15 (actual); primary completion 2026-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vasoactive Drugs in Intensive Care Unit
Condition
Shock
Intervention (Drug)
Norepinephrine
Intervention (Drug)
Epinephrine
Intervention (Drug)
Phenylephrine
Intervention (Drug)
Vasopressin
Lead sponsor
University of Chicago (class: other)

Record details

Record id
cardio:ct-nct02118467
Content hash
29216bb2b69890d319486b213f8f2a1474288ace29b0d66660bfee8e115d8852